Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase. - Wikidata - wikimedia - TriplyDB

Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase.

Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase.

http://www.wikidata.org/entity/Q36284750

about

Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease.CD4 Depletion or CD40L Blockade Results in Antigen-Specific Tolerance in a Red Blood Cell Alloimmunization Model.Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond.Drug delivery by erythrocytes: "Primum non nocere".Reengineering red blood cells for cellular therapeutics and diagnostics.In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance.Targeting and delivery of therapeutic enzymes.Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.Engineered red blood cells as therapeutic agents.Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles.The Modified Heparin-Binding L-Asparaginase of Wolinella succinogenes.

P2860

Q37730171-0176E402-BD5E-472F-91E4-7E490677E451 Q38616688-BBF91CA0-225E-4CAF-AA7E-7D77450816D9 Q38760096-06A0E26D-0CF5-4EE8-86A9-74FDFC166F36 Q38972974-F5095835-8DDA-4C42-89B2-3312F4D97933 Q39011174-2AFCF5FE-D9FA-492F-85A6-3AB28A9A33F8 Q39100275-CC673E94-D995-4A72-86A0-ECA2F0782177 Q39245827-7ECEE451-4271-4A75-B1D1-25ED0381F152 Q39386527-D3426EF9-638B-49CD-8BA7-872D7D0D90A4 Q40933700-BC2C0C13-6A1A-484A-B4B5-3C26B262FB15 Q47210721-A5FD7A2D-7BD2-4597-A002-3BC92C13D1EC Q47859467-179DA7B0-BF3B-4E8B-AD27-2C3A31C3BEFC Q51602149-1633E68B-74F7-40FE-867A-EBD912CDBB3A Q54245410-F6AB4F9B-2467-459B-A52A-B2182C301B94

P2860

Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase.

http://www.wikidata.org/entity/Q36284750

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Engineered binding to erythroc ...... rance to E. coli asparaginase.

@ast

Engineered binding to erythroc ...... rance to E. coli asparaginase.

@en

type

label

Engineered binding to erythroc ...... rance to E. coli asparaginase.

@ast

Engineered binding to erythroc ...... rance to E. coli asparaginase.

@en

prefLabel

Engineered binding to erythroc ...... rance to E. coli asparaginase.

@ast

Engineered binding to erythroc ...... rance to E. coli asparaginase.

@en

P1433

Q36284750-2A4012B1-D649-44BE-A174-79DC38704ABE

P1476

Q36284750-8838C88D-2AED-49A3-B297-5BD781132C4C

P2093

Q36284750-47D9104B-B180-4C8A-AFC9-7C29CBD45B36

Q36284750-AEA5CE3A-B656-44B5-97B8-66C93D219A2C

Q36284750-BE35A75A-70B3-440F-BC94-81B7C7699DBC

Q36284750-E5A2B66A-3BA6-4307-99DA-8FD02F7510AA

P2860

Q36284750-02727AAE-4AC3-43B4-897C-F66F7E26C123

Q36284750-056F45CC-A731-4F19-92BB-249A026E98CB

Q36284750-0AF2A449-58E9-42D2-BC6F-B32A34E7B384

Q36284750-11202A55-8E5D-4839-818E-854C85C39421

Q36284750-29B39E8D-9A06-4A02-B6FB-DE369746FBAC

Q36284750-2A2C55A3-3C23-487B-8215-0CBC4369C9FC

Q36284750-2E6BC5DD-E8DA-4AFF-BBA2-753133B11C40

Q36284750-306D5C60-4745-4D68-873A-B3D3A71CE855

Q36284750-3FBF87B1-5F17-49E7-B0E0-EC37C4CC1CE5

Q36284750-5028875A-E149-4FEB-87EE-1B6011406C47

P304

Q36284750-FDDAEE34-5680-4ECD-9FF9-5EB0827891EB

P31

Q36284750-EADFAA6D-40FE-40A8-804C-756A79DDB765

P356

Q36284750-0367762A-E736-4A98-83A6-4B9D1CD30C2B

P433

Q36284750-8A2F2CED-5454-47CB-B2EF-EDE15D2771A7

P478

Q36284750-C494D41B-529E-4529-8A15-10E180585756

P50

Q36284750-6F9564D3-42D0-43A1-A37D-E4098C5FD498

P577

Q36284750-24EF1BE2-96FE-4B07-9CC8-B95C8340B78E

P5875

Q36284750-791C3541-7DF7-4CFD-A5E0-550368212937

P698

Q36284750-234C7D2A-D79E-4C97-AA66-B2203CC8C576

P921

Q36284750-E6C91F7D-70FF-4C5A-80C7-069C3C5EF614

P932

Q36284750-A7CB0092-2FF5-4BAB-8A96-1B07F1421841

P356

P1433

Science Advances

P1476

Engineered binding to erythroc ...... rance to E. coli asparaginase.

@en

P2093

Hugues Henry

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Hubbell

http://www.w3.org/2001/XMLSchema#string

Kristen M Lorentz

http://www.w3.org/2001/XMLSchema#string

Stephan Kontos

http://www.w3.org/2001/XMLSchema#string

P2860

Immunogenicity of protein therapeutics: The key causes, consequences and challenges

Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells

Structure-guided deimmunization of therapeutic proteins

FcgammaRIV: a novel FcR with distinct IgG subclass specificity

Immunogenic and tolerogenic cell death.

Improving protein pharmacokinetics by engineering erythrocyte affinity.

Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients

Aging of the T cell compartment in mice and humans: from no naive expectations to foggy memories.

Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes.

Phosphatidylserine reduces immune response against human recombinant Factor VIII in Hemophilia A mice by regulation of dendritic cell function.

P304

e1500112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIADV.1500112

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Giacomo Diaceri

P577

2015-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281978701

http://www.w3.org/2001/XMLSchema#string

P698

26601215

http://www.w3.org/2001/XMLSchema#string

P921

Escherichia coli

P932

4646778

http://www.w3.org/2001/XMLSchema#string